Clinical Roundup Combination immunotherapy shows high activity against recurrent Hodgkin lymphoma December 07, 2018Vol.44 No.45
Clinical Roundup Karyopharm reports positive top-line phase IIb SADAL data for Selinexor in diffuse large B-cell lymphoma December 07, 2018Vol.44 No.45
Clinical Roundup Celgene announces initial phase I/II liso-cel data in patients with r/r CLL December 07, 2018Vol.44 No.45
Clinical Roundup Avelumab in platinum-resistant/refractory ovarian cancer did not meet OS and PFS endpoints November 30, 2018Vol.44 No.44
Clinical RoundupFree Biodesix test predicts response to atezolizumab in lung cancer November 16, 2018Vol.44 No.43
Clinical RoundupFree Cardiovascular toxicities seen early in treatment with immune checkpoint inhibitors November 16, 2018Vol.44 No.43
Clinical RoundupFree Gradalis presents initial data from phase II U.S. trial for Ewing’s sarcoma November 16, 2018Vol.44 No.43
Clinical RoundupFree Keytruda significantly improved OS compared to chemotherapy in PD-L1 advanced esophageal or esophagogastric junction carcinoma November 16, 2018Vol.44 No.43
